High Factor X plasma > 150 % (acquired)

Frozen

Packaging options

6-PP10H	Vial	1 x 1.0 mL

Description of the High Factor X plasma > 150 % (acquired)

Advantages

Minimize test time.
Ready to use.

Informations

Factor X (FX) is a glycoprotein synthesized by the liver, dependent on vitamin K. FX is involved in the common pathway of coagulation. It is activated in FXa by the FT-FVIIa complex or by the FVIIIa-FIXa complex in the presence of phospholipids. FXa is neutralized by TFPI and antithrombin.

product sheet

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

High Factor X plasma > 150 % (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

My personal Space

Nouveau client

High Factor X plasma > 150 % (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

Associated products

Factor XIII High > 150 % (acquired)

High Factor II plasma (acquired) > 150 %

High Factor II plasma (G20210A positive mutation) > 150%

High Factor IX plasma > 150 % (acquired)

High Factor V plasma (acquired) > 150 %

High Factor XI plasma > 150 % (acquired)

High Factor XII plasma > 150 % (acquired)

High FVII plasma 100-150 % (acquired)

High FVIII plasma > 150 % (acquired)